Astrazeneca Pharma India

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue319.44315.45391.86395.87416.15
Expenses262.49295.05337.50353.47365.12
EBITDA61.1324.7158.0546.4260.69
EBIT73.8821.0154.29-15.0551.37
Profit Before Tax73.3820.4054.36-15.1651.03
Net Profit52.3715.8039.48-11.7938.43
Financial Ratios
Operating Profit Margin24.93%8.08%15.15%-2.87%14.88%
Net Profit Margin13.09%5.17%10.30%9.04%9.42%
Earning Per Share (Diluted)20.956.3215.79-4.7216.37
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ